Back to Feed
ClinicalTrials.gov|Clinical Trial
Long-term Follow-up of Subjects Treated With CAR T Cells
Marcela V. Maus, M.D.,Ph.D.
Abstract
This is a single site, non-randomized, open-label, long-term safety and efficacy follow-up study for Phase 1 studies that evaluate the safety and efficacy of CAR T cells: NCT05660369 (DF/HCC# 22-175) and NCT06026319 (DF/HCC# 23-474). Status: RECRUITING Conditions: Long Term Adverse Effects; CAR-T; Duty to Follow Up; Adult; Progression-Free Survival; Disease-Free Survival; Overall Survival Interventions: Disease assessments; Tumor Biopsy; Blood test
Keywords
Long Term Adverse EffectsCAR-TDuty to Follow UpAdultProgression-Free SurvivalDisease-Free SurvivalOverall Survival